1-6 of 6
Iwona Solarska, PhD
Close
Sort by
Journal Articles

ASXL1 Mutations Detectable at Diagnosis May Predict Response to Imatinib in Patients with Chronic Myeloid Leukemia

Marcin M Machnicki, MSc, Monika Pepek, MSc, Iwona Solarska, PhD, Joanna Niesiobedzka-Krezel, MD PhD, Ilona Seferynska, MD PhD, Joanna Gora Tybor, MD PhD, Magdalena Zawada, PhD, Tomasz Sacha, MD PhD, Waldemar Sawicki, MD PhD, Ewa Wasilewska, MD PhD, Katarzyna Pruszczyk, MD, Malgorzata Rydzanicz, PhD, Rafal Ploski, MD PhD, Tomasz Skorski, MD PhD, Tomasz Stoklosa, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4148.
https://doi.org/10.1182/blood-2019-129834
Published: 2019
Journal Articles

The Role of Shelterin Complex and Post-Translational Non-Enzymatic Modification in Telomere Maintenance in Chronic Myeloid Leukemia

Anna Deregowska, MSc, Katarzyna Pruszczyk, MD, Iwona Solarska, PhD, Ilona Seferynska, MD PhD, Marek Dudzinski, MD, Maciej Wnuk, PhD, Tomasz Stoklosa, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5426.
https://doi.org/10.1182/blood-2018-99-112879
Published: 2018
Journal Articles

Role of Shelterin Complex and Alternative Telomere Lengthening in Genomic Instability and Disease Progression in Chronic Myeloid Leukemia

Tomasz Stoklosa, MD PhD, Anna Deregowska, Katarzyna Pruszczyk, Iwona Solarska, PhD, Marcin M Machnicki, Jagoda Adamczyk, Ilona Seferynska, Anna Lewinska, PhD, Maciej Wnuk, PhD
Journal: Blood
Blood (2016) 128 (22): 1880.
https://doi.org/10.1182/blood.V128.22.1880.1880
Published: 2016
Journal Articles

Somatic Mutations in Commonly Mutated Genes in Myeloid Malignancies May Preexist or Arise in the Course of Chronic Myeloid Leukemia - Different Scenarios of Progression Revealed By Targeted Next-Generation Sequencing

Marcin M Machnicki, Iwona Solarska, PhD, Rafal Ploski, MD PhD, Ilona Seferynska, MD PhD, Tomasz Stoklosa, MD PhD
Journal: Blood
Blood (2015) 126 (23): 2771.
https://doi.org/10.1182/blood.V126.23.2771.2771
Published: 2015
Journal Articles

Differential Expression of BIRC Family Genes In The Course Of Chronic Myeloid Leukemia – BIRC3 and BIRC8 As Potential New Candidates To Identify Disease Progression

Eliza Glodkowska-Mrowka, MD, Iwona Solarska, PhD, Piotr Mrowka, PhD, Katarzyna Bajorek, MSc, Joanna Niesiobedzka-Krezel, MD, Ilona Seferynska, MD, PhD, Katarzyna Borg, PhD, Tomasz Stoklosa, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 2718.
https://doi.org/10.1182/blood.V122.21.2718.2718
Published: 2013
Journal Articles

Significance of Minimal Residual Disease in Patients with Chronic Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation.

Iwona Solarska, PhD, Barbara Nasilowska-Adamska, MD, PhD, Maria Bieniaszewska, MD, PhD, Jan Maciej Zaucha, MD, PhD, Piotr Rzepecki, MD, PhD, Waldemar Sawicki, MD, Malgorzata Calbecka, MD, Ewa Lech-Maranda, MD, PhD, Bozena Marianska, MD, PhD, Krzysztof Warzocha, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 3269.
https://doi.org/10.1182/blood.V114.22.3269.3269
Published: 2009